加载中
NYSEHealthcareMedical - Diagnostics & Research
最新数据
US$662.06
+US$5.48 · +0.83%
Thermo Fisher Scientific Inc. is a global leader in scientific services, providing a comprehensive range of offerings that include life sciences solutions, advanced analytical instruments, specialized diagnostic products, and an extensive portfolio of laboratory supplies and biopharmaceutical services. The company's reach extends across North America, Europe, Asia-Pacific, and other international markets. Its Life Sciences Solutions division furnishes researchers with essential reagents, state-of-the-art instruments, and consumables vital for biological and medical exploration, the development and manufacturing of therapeutics and vaccines, and the detection of infections and various diseases. This segment encompasses bioscience, genetic science, and bioproduction technologies, serving a broad spectrum of clients in the pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and governmental sectors. The Analytical Instruments segment delivers a variety of precision instruments, consumables, software, and support services to pharmaceutical, biotechnology, academic, governmental, environmental, and industrial research environments, as well as clinical laboratories. The Specialty Diagnostics segment offers an array of diagnostic tools, including liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, alongside calibrators, controls, protein detection assays, and accompanying instruments. This also features the creation and distribution of complete blood test systems to aid in the clinical diagnosis and monitoring of allergies, asthma, and autoimmune diseases. Furthermore, it provides dehydrated and prepared culture media, specimen collection and transport systems, related instrumentation and consumables, human leukocyte antigen (HLA) typing and testing crucial for the organ transplant sector, and other healthcare products. Lastly, the Laboratory Products and Biopharma Services segment supplies laboratory equipment, serves the research and safety markets through its channels, and offers extensive pharmaceutical services, encompassing clinical research support. The company's products and services are distributed through a dedicated direct sales team, customer service professionals, online commerce platforms, and a network of third-party distributors. Its recognized brands include Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon, and PPD. Thermo Fisher Scientific Inc. was established in 1956 and is headquartered in Waltham, Massachusetts.
前收盘价
US$662.06
+US$5.48 · +0.83%
盘前
US$659.99
−US$2.07 · -0.31%
10月8日 9:00 ET
盘中时间采用ET。市场数据可能有所延迟。
Thermo Fisher Scientific Inc. is a global leader in scientific services, providing a comprehensive range of offerings that include life sciences solutions, advanced analytical instruments, specialized diagnostic products, and an extensive portfolio of laboratory supplies and biopharmaceutical services. The company's reach extends across North America, Europe, Asia-Pacific, and other international markets. Its Life Sciences Solutions division furnishes researchers with essential reagents, state-of-the-art instruments, and consumables vital for biological and medical exploration, the development and manufacturing of therapeutics and vaccines, and the detection of infections and various diseases. This segment encompasses bioscience, genetic science, and bioproduction technologies, serving a broad spectrum of clients in the pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and governmental sectors. The Analytical Instruments segment delivers a variety of precision instruments, consumables, software, and support services to pharmaceutical, biotechnology, academic, governmental, environmental, and industrial research environments, as well as clinical laboratories. The Specialty Diagnostics segment offers an array of diagnostic tools, including liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, alongside calibrators, controls, protein detection assays, and accompanying instruments. This also features the creation and distribution of complete blood test systems to aid in the clinical diagnosis and monitoring of allergies, asthma, and autoimmune diseases. Furthermore, it provides dehydrated and prepared culture media, specimen collection and transport systems, related instrumentation and consumables, human leukocyte antigen (HLA) typing and testing crucial for the organ transplant sector, and other healthcare products. Lastly, the Laboratory Products and Biopharma Services segment supplies laboratory equipment, serves the research and safety markets through its channels, and offers extensive pharmaceutical services, encompassing clinical research support. The company's products and services are distributed through a dedicated direct sales team, customer service professionals, online commerce platforms, and a network of third-party distributors. Its recognized brands include Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon, and PPD. Thermo Fisher Scientific Inc. was established in 1956 and is headquartered in Waltham, Massachusetts.
日内区间
当前US$662.06
52周区间
当前US$662.06
盘中时间采用ET。市场数据可能有所延迟。
Thermo Fisher Scientific Inc. is a global leader in scientific services, providing a comprehensive range of offerings that include life sciences solutions, advanced analytical instruments, specialized diagnostic products, and an extensive portfolio of laboratory supplies and biopharmaceutical services. The company's reach extends across North America, Europe, Asia-Pacific, and other international markets. Its Life Sciences Solutions division furnishes researchers with essential reagents, state-of-the-art instruments, and consumables vital for biological and medical exploration, the development and manufacturing of therapeutics and vaccines, and the detection of infections and various diseases. This segment encompasses bioscience, genetic science, and bioproduction technologies, serving a broad spectrum of clients in the pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and governmental sectors. The Analytical Instruments segment delivers a variety of precision instruments, consumables, software, and support services to pharmaceutical, biotechnology, academic, governmental, environmental, and industrial research environments, as well as clinical laboratories. The Specialty Diagnostics segment offers an array of diagnostic tools, including liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, alongside calibrators, controls, protein detection assays, and accompanying instruments. This also features the creation and distribution of complete blood test systems to aid in the clinical diagnosis and monitoring of allergies, asthma, and autoimmune diseases. Furthermore, it provides dehydrated and prepared culture media, specimen collection and transport systems, related instrumentation and consumables, human leukocyte antigen (HLA) typing and testing crucial for the organ transplant sector, and other healthcare products. Lastly, the Laboratory Products and Biopharma Services segment supplies laboratory equipment, serves the research and safety markets through its channels, and offers extensive pharmaceutical services, encompassing clinical research support. The company's products and services are distributed through a dedicated direct sales team, customer service professionals, online commerce platforms, and a network of third-party distributors. Its recognized brands include Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon, and PPD. Thermo Fisher Scientific Inc. was established in 1956 and is headquartered in Waltham, Massachusetts.
日内区间
当前US$662.06
52周区间
当前US$662.06
盈利能力占已公布营收的百分比。
营收
营业利润
净利润
| 项目（USD） | 2025财年 | 2024财年 | 2023财年 | 2022财年 | 2021财年 |
|---|---|---|---|---|---|
| 营收 | 445.57亿 USD | 428.79亿 USD | 428.57亿 USD | 449.15亿 USD | 392.11亿 USD |
| 销货成本 | 263.18亿 USD | 251.51亿 USD | 256.63亿 USD | 259.04亿 USD | 195.77亿 USD |
| 毛利 | 182.39亿 USD | 177.28亿 USD | 171.94亿 USD | 190.11亿 USD | 196.34亿 USD |
| 研究与开发 | 13.97亿 USD | 13.9亿 USD | 13.37亿 USD | 14.71亿 USD | 14.06亿 USD |
| 销售、一般及管理费用 | 87.32亿 USD | 86.76亿 USD | 84.11亿 USD | 90.15亿 USD | 79.1亿 USD |
| 营业费用 | 101.29亿 USD | 100.66亿 USD | 97.48亿 USD | 104.86亿 USD | 93.16亿 USD |
| 利息收入 | 9.93亿 USD | 10.78亿 USD | 8.79亿 USD | 2.72亿 USD | 4300万 USD |
| 利息支出 | 14.19亿 USD | 16.54亿 USD | 14.91亿 USD | 7.26亿 USD | 5.36亿 USD |
| 折旧和摊销 | 27.8亿 USD | 31.08亿 USD | 34.06亿 USD | 33.81亿 USD | 25.92亿 USD |
| 营业利润 | 81.09亿 USD | 76.62亿 USD | 74.46亿 USD | 85.25亿 USD | 103.18亿 USD |
| 净利润 | 67.37亿 USD | 63.35亿 USD | 59.95亿 USD | 69.5亿 USD | 77.25亿 USD |
公司数据更新于 2026年10月8日。
近期已公布业绩
近期已公布业绩
第三方分析师预期可能变化，并非 GoAI 建议。
平均目标
US$640.54
下跌空间 3.25%报告持有此股票敞口的交易所交易基金。
State Street SPDR S&P 500 ETF1557.T4673.01亿0.36%129.41万亿 JPY0.09%JP¥122,700-0.57%
Vanguard Morningstar Total Stock Market ETFVTI72.88亿0.31%2.3万亿 USD0.03%US$381.03-0.40%
Vanguard S&P 500 ETFVOO60.92亿0.35%1.8万亿 USD0.03%US$714.34-0.26%
iShares Core S&P 500 ETFIVV32.34亿0.36%8996.25亿 USD0.03%US$780.58-0.25%
State Street SPDR S&P 500 ETFSPY29.51亿0.36%8190.39亿 USD0.09%US$777.22-0.24%
Vanguard Morningstar Value ETFVTV21.92亿0.83%2624亿 USD0.03%US$218.21-0.37%
State Street Health Care Select Sector SPDR ETFXLV17.26亿4.00%431.09亿 USD0.08%US$168.81+1.03%
Vanguard Health Care ETFVHT7亿3.17%220亿 USD0.09%US$315.31+0.78%State Street SPDR S&P 500 ETF1557.TVanguard Morningstar Total Stock Market ETFVTIVanguard S&P 500 ETFVOOiShares Core S&P 500 ETFIVVState Street SPDR S&P 500 ETFSPYVanguard Morningstar Value ETFVTVState Street Health Care Select Sector SPDR ETFXLVVanguard Health Care ETFVHTAI 生成内容及延迟市场数据仅供信息与教育用途，不构成投资建议。
